Building Resilient Futures: Fashion Leaders Convene to Chart a Path from Risk to Renewal
Press Release

Building Resilient Futures: Fashion Leaders Convene to Chart a Path from Risk to Renewal

COPENHAGEN, Denmark, May 8, 2026 /PRNewswire/ — From 5-7 May, Global Fashion Summit: Copenhagen Edition 2026 convened over 1000 stakeholders from brands, retailers, NGOs, policymakers, manufacturers, innovators, and adjacent industries to advance collective action on fashion’s sustainability challenges and opportunities. Presented by Global Fashion Agenda (GFA), the non-profit accelerating the transition to a net positive fashion […]

Read More
Cellebrite Announces Participation in Upcoming Investor Conferences
Press Release

Cellebrite Announces Participation in Upcoming Investor Conferences

TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 8, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions, today announced that the Company plans to participate in the following investor conferences in May and June: Date: May 18, 2026 Conference: J.P. Morgan 2026 Global Technology, Media and […]

Read More
AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
Press Release

AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest

ROCKVILLE, Md., May 8, 2026 /PRNewswire/ — USA — AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and cost effectiveness. AAVone®2.1 has achieved ~1×1016 genome copies (GC)/L of cell culture and greater than 70% […]

Read More
Pony.ai Labor Day Holiday Robotaxi Paid Orders Surge More Than Sixfold
Press Release

Pony.ai Labor Day Holiday Robotaxi Paid Orders Surge More Than Sixfold

GUANGZHOU, China, May 8, 2026 /PRNewswire/ — Pony AI Inc. ("Pony.ai") (NASDAQ: PONY; HKEX: 2026), a global leader in the large-scale commercialization of autonomous driving technology, reported a sharp increase in robotaxi demand during China’s Labor Day holiday from May 1 to 5, with average daily paid robotaxi orders rising 544% year over year, driven […]

Read More
Govee Outdoor String Light Bulb Series: Elevating Smart Outdoor Lighting with Versatile, Simple Solutions
Press Release

Govee Outdoor String Light Bulb Series: Elevating Smart Outdoor Lighting with Versatile, Simple Solutions

BELLEVUE, Wash., May 8, 2026 /PRNewswire/ — Govee, a global leader in smart lighting innovation, showcases the diversity of its smart outdoor lighting through the Outdoor String Light Bulb Series. The portfolio offers five unique designs tailored to different outdoor spaces, simplifying the lighting selection process, and providing an effortless solution for backyard upgrades. Govee […]

Read More
AUTOCRYPT Recognized for Cybersecurity Excellence in Vehicle Key Lifecycle Management at AutoTech 2026
Press Release

AUTOCRYPT Recognized for Cybersecurity Excellence in Vehicle Key Lifecycle Management at AutoTech 2026

NOVI, Mich., May 8, 2026 /PRNewswire/ — AUTOCRYPT, a leading automotive and AI cybersecurity solutions provider, announced that its Automotive KMI solution has been shortlisted for the Cybersecurity Excellence Award category at the 2026 AutoTech Awards. The recognition highlights AUTOCRYPT’s role in advancing trusted cybersecurity infrastructure as global regulations and software-defined mobility ecosystems continue to […]

Read More
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
Press Release

The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

CHENGDU, China, May 8, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company’s TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) was accepted for review by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China. The […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.